Tag Archives: xarelto

Act Now For Xarelto Suits: Time Running Out

We have been keeping you up-to-date on the progress of the Xarelto multidistrict litigations, so we wanted to let you know that time is running out for any victims who have suffered injuries or lost loved ones due to this potentially harmful drug. Act Now For Xarelto Suits On September 17th, Judge Eldon Fallon signed a court order to begin selecting dates for the trials that would help speed the legal processes for the thousands of cases against the makers of Xarelto. These trials are called bellwether trials and they are expected to begin during the fall of 2016. That means that the multidistrict litigation could stop accepting new claims soon. How Will The Xarelto Multidistrict Litigation Work? There will be four trials that represent the interests of thousands of plaintiffs, and they will take place in Louisiana, Mississippi, and Texas. However, people from all over the country—including Florida natives—will…
Read More »

Posted in Pharmaceutical Litigation | Tagged | 2 Comments

Xarelto Cases Fast Approaching Court Date

More news on our continued coverage of the Xarelto mass tort cases: June 11th is fast approaching, a significant day for members of the Xarelto federal multidistrict litigation. That day is when the attorneys for the plaintiffs get to present their scientific evidence to the court, and drive home their claims that they have linked bleeding complications to improperly disclosed Xarelto side effects. Xarelto is a blood-thinning drug, one of the newest, and it is used to treat medical conditions such as deep vein thrombosis and atrial fibrillation. The characteristics of such a drug raise the possibility of bleeding, or hemorrhaging, which can be fatal. Warfarin, the predecessor of Xarelto, holds the same risk, but can easily be reversed with the administration of Vitamin K. The lack of a reversing agent, as well as understated yet potentially dangerous side effects, has led to over 300 MDL lawsuits. Their day in…
Read More »

Posted in Pharmaceutical Litigation | Tagged | Leave a comment

Xarelto Lawsuits Progress as Court Approves New Documents for Plaintiff Filing

The lawsuits concerning the pharmaceutical drug Xarelto picked up steam this past week as documents allowing for coordinated pretrial proceedings were approved in the U.S. District Court in Eastern Louisiana and in Pennsylvania’s Court of Common Pleas. As this blog has noted in the past, plaintiffs have asserted that the blood thinning drug causes uncontrollable bleeding, and that the bleeding caused by Xarelto cannot be reversed as with other blood thinners like Warfarin. A court order from March 24 will now allow new plaintiffs in the Louisiana litigation to file cases directly in the proceeding. The Pennsylvania court will allow plaintiffs to submit a Master Long Form Complaint to have their cases join the others that have already been filed. Both developments are signs that the lawsuits are moving forward and will probably continue to grow as more plaintiffs come forward. The coordination of the pretrial proceedings should make the…
Read More »

Posted in Pharmaceutical Litigation | Tagged , | Leave a comment